Ponatinib- vs Dasatinib-Based Induction in Adults With Newly Diagnosed Ph+ ALLByDubi Yoo, PharmD,Jose Tinajero, PharmD, BCOP,Ibrahim Aldoss, MDJune 19th 2026This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.